These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7473681

  • 1. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ, Jenkins PA, Furr JR, Russell AD.
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
    van Ingen J, Hoefsloot W, Mouton JW, Boeree MJ, van Soolingen D.
    Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of the antimycobacterial activity of biocides.
    Russell AD, Broadley SJ, Furr JR, Jenkins PA.
    J Infect; 1994 Jan; 28(1):108-9. PubMed ID: 8163826
    [No Abstract] [Full Text] [Related]

  • 5. In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
    Kaur D, Khuller GK.
    Int J Antimicrob Agents; 2001 Jan; 17(1):51-5. PubMed ID: 11137649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
    Zimmer BL, DeYoung DR, Roberts GD.
    Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA, Ocampo-Candiani J, Rendón A, Pucci MJ, Vera-Cabrera L.
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime.
    Abate G, Hoffner SE.
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):119-22. PubMed ID: 9294701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.
    Yates MD, Collins CH.
    Tubercle; 1981 Jun; 62(2):117-21. PubMed ID: 7303160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M, Gutierrez J, Ruiz P, Moreno G.
    Chemotherapy; 1995 Jun; 41(3):204-7. PubMed ID: 7656667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.